Dexrazoxane Intravenous and Linagliptin and metformin
Determining the interaction of Dexrazoxane Intravenous and Linagliptin and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Linagliptin and Metformin Extended-Release Tablets
- Dexrazoxane Intravenous-Linagliptin and Metformin Tablets
- Dexrazoxane Intravenous-Lincocin
- Dexrazoxane Intravenous-Lincomycin
- Dexrazoxane Intravenous-Lincomycin Hydrochloride
- Dexrazoxane Intravenous-Lincomycin Injection
- Linagliptin and metformin-Dextenza Insert
- Linagliptin and metformin-Dextenza intraocular
- Linagliptin and metformin-Dextran 40
- Linagliptin and metformin-Dextran 70 6% in 5% Dextrose high molecular weight
- Linagliptin and metformin-Dextran 75
- Linagliptin and metformin-Dextran high molecular weight